Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Clinical Nephrology|April 1, 1984
The value of autologous indium (111In)-labelled platelets in the diagnosis of renal transplant rejectionA Fenech, F W Smith, D A Power, et al.Transplantation|January 1, 1985
Cyclosporine-induced fetotoxicity in the ratR J Mason, A W Thomson, P H Whiting, et al.Lancet (London, England)|September 24, 1983
The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigensD A Power, G R Catto, R J Mason, et al.American Journal of Reproductive Immunology and Microbiology : AJRIM|April 1, 1986
Differential expression of trophoblast lymphocyte cross-reactive (TLX) antigens on T and B lymphocytesA M MacLeod, G R Catto, K N Stewart, et al.International Journal of Microcirculation, Clinical and Experimental|January 1, 1985
Functional characteristics of the glomerular filter in the IgA-nephropathyP Langhorne, P H Whiting, J Petersen, et al.British Journal of Cancer|November 21, 1998
A phase II study of bryostatin 1 in metastatic malignant melanomaD J Propper, V Macaulay, K J O'Byrne, et al.Clinical Science (London, England : 1979)|July 1, 1985
Prolonged survival of rat renal allografts after multiple allogeneic pregnancies: strain specificity and role of erythrocyte antibody rosette inhibiting antibodiesS K Asfar, D A Power, R J Mason, et al.British Journal of Cancer|June 6, 2000
Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazineD J Propper, J P Braybrooke, N C Levitt, et al.Transplantation|May 1, 1985
Evidence that protective Fc-receptor-blocking antibodies in renal transplantation are alloantibodies not autoantibodiesA M MacLeod, R J Mason, D A Power, et al.Cancer Chemotherapy and Pharmacology|February 9, 2000
Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifenJ P Braybrooke, S Houlbrook, J E Crawley, et al.Pageof 12